Investment Update

RNS Number : 1104X
Intl. Biotechnology Trust PLC
31 December 2021
 

31 December 2021

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

 

 

Investment Update

 

In accordance with the Company's strategy to maintain its exposure to unquoted companies within a 5%-15% of NAV range, the Board of International Biotechnology Trust plc has made the decision to invest in SV Health Investors' forthcoming biotechnology focussed private fund, SV Biotech Crossover Opportunities Fund LP.

 

For further information contact:

 

 

Company Secretary - Link Company Matters

 

Indu Shastri  + 44 (0)7936 045789

 

LEI: 213800N1QUJ744P76D11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZMFZRGKGMZM

Companies

International Biotech Trust (IBT)
Investor Meets Company
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today